Lymphocytes are more likely to make an immune response if costimulatory and antigen receptors coincidently signal; the way the signals are integrated illustrates how a lymphocyte learns to distinguish self from foreign antigens, and provides a model for coincident signaling through more than one receptor.
The most important choice a lymphocyte must make is whether or not to mount an immune response against an antigen. Normal responses triggered through binding of antigen to antigen-specific receptors on B and T cells distinguish between infectious foreign antigens, which elicit an immune response, and self antigens, which elicit a tolerance response. Foreign antigens are distinguished from self antigens in part by the context of their detection by lymphocytes. One way that lymphocytes detect the context of the antigen is through the use of costimulatory receptors, such as CD19 on B cells and CD28 on T cells.
In molecular terms, the lymphocyte must process signals through both its antigen receptor and coreceptor. The way in which these signals are integrated is important, both in understanding immune responses and as a paradigm for understanding the coordination of signaling by two or more cell-surface receptors. In recent years, it has been shown that autoimmune responses to self antigens can be precipitated by disregulation of the CD19 or CD28 pathways [1] [2] [3] . We shall consider the similar functions of CD28 on T cells and CD19 on B cells as costimulatory receptors, and discuss how signals generated by these coreceptors change the quality and quantity of signals through the antigen receptor.
Tolerance and immunity decisions in lymphocytes
When T cells and B cells bind their specific antigen in the appropriate context, they make an 'immunity' response. This is characterized by proliferation for both T and B cells. The B cells go on to become antibody-secreting plasma cells; the T cells make cytokines, such as interleukin-2 (IL-2), and, in the case of the cytotoxic T cells, kill targets. But if antigen is bound at the wrong time in developmentfor example, to developing T cells in the thymus -or if antigen is bound in the wrong context -for example, without costimulatory signals -the lymphocyte makes a 'tolerance' response. The simplest tolerance response is to die; this happens to maturing B cells in the bone marrow and to thymocytes undergoing negative selection in the thymus. Alternatively, B and T cells may become functionally tolerant, or 'anergic' to further antigenic stimulation. Anergic T cells proliferate weakly and make little IL-2 in response to antigen, but can make other cytokines [4] . Anergic B cells also proliferate weakly in response to antigen stimulation, but still change their migratory patterns [5] . Upon antigen binding, a lymphocyte must decide whether to mount an immune response or to become tolerant.
As mentioned above, one factor that contributes to the tolerance or immunity decision is the developmental stage of the lymphocyte when it encounters an antigen that it recognizes. Another important factor is the nature of the antigen -its concentration, avidity for the lymphocyte's antigen receptor, and the duration of exposure. A third factor is the context in which the antigen is detected or, specifically, what costimulatory molecules are associated with the antigen. Ligands for costimulatory receptors are produced in response to pathogenic challenge. These ligands help to indicate the presence of a foreign invader that would require an immune response from the specific T cell or B cell binding antigen in that region.
CD28 costimulation of T cells
The costimulatory receptor CD28 forms a transmembrane homodimer that is present on most T cells. CD28 binds to B7.1 and B7.2, surface proteins present on antigenpresenting cells, such as B cells (Figure 1 ). B7 family members are produced in response to foreign infection and thus indicate the need for an immune response. Stimuli that lead to upregulation of B7 proteins include structural components of bacteria, such as lipopolysaccharide, antigen binding to B cells, and tumor necrosis factor α (TNFα), which is produced following cell injury [6] .
When a T cell is acutely stimulated by antigen through its T-cell antigen receptor, and at the same time costimulated by B7.1 or B7.2 through the CD28 coreceptor, the combined signal stimulates the T cell to produce IL-2 and proliferate, and prevents anergy [7, 8] .
The key role of CD28 stimulation has been firmly established by a variety of experimental approaches in mice. Blocking the ligation of CD28 diminishes T-cell immune responses to a range of stimuli in vivo [6] . Early experiments demonstrated the importance of the CD28-B7 interaction for transplant rejection. Since then, mice lacking CD28 or expressing a soluble CD28 antagonist (CTLA4Ig) have shown deficient immune responses. The suppression of autoimmune disease by blocking CD28 ligation has been shown in several mouse models, including mice with autoimmune diabetes or experimental autoimmune encephalomyelitis [6] . Conversely, expression of B7.1 or B7.2 in an inappropriate context, such as on pancreatic islet β cells [2, 3] or self-tolerant B cells (our unpublished data), can provoke autoimmune responses when tolerance would normally be the outcome.
CD19 costimulation of B cells
Antigen binding to the B-cell antigen receptor causes analogous biochemical and biological effects to antigen binding to the T-cell receptor. B-cell receptor ligation results in B-cell proliferation and induces expression of T-cell costimulatory molecules such as B7.2, priming the B cell to produce antibodies. Like CD28 on T cells, activation of the CD19 costimulatory receptor complex on B cells changes the outcome of antigen-receptor ligation.
CD19 is a transmembrane protein made constitutively by B cells. On its own, CD19 may act as a receptor for an as yet unidentified ligand. But in association with the complement-binding chain CD21, CD19 forms the signaling subunit of the CR2 complement receptor (Figure 1 ) [9] . The complement system is a proteolytic cascade of interacting serum proteins that is selectively triggered by distinctive properties of foreign microorganisms, such as charge, glycosylation patterns or the absence of anticomplement regulatory proteins. Once triggered, cleavage products of the third complement component, C3b and C3d, are covalently attached to foreign antigens, tagging them for destruction (C3b) or for immune responses (C3d).
When a B cell is acutely stimulated by antigen through its B-cell receptor and simultaneously costimulated by attached C3d via its complement receptor complex, the combined signal synergistically augments B-cell activation and antibody production [10] . Antibody responses are markedly reduced in animals lacking C3, CD21 or CD19, or when C3 is depleted or blocked by soluble fusion proteins [9, 11] . These results parallel the effects of blocking the B7-CD28 pathway in T cells. Moreover, just as inappropriate expression of B7 can provoke autoimmunity in T cells, disregulated expression of CD19 can provoke spontaneous autoantibody production by B cells that would otherwise remain tolerant [1] .
Signaling pathways affected by coreceptors
How do CD28 and CD19 alter the way B and T cells respond to antigen, shifting the balance away from tolerance and towards immunity? This active area of research is sometimes controversial, in part because of the range of cell models and stimuli used. Nevertheless, biochemical studies strengthen the parallels between CD28 and CD19, indicating that both coreceptors change the quality and quantity of antigen-receptor signals.
Antigen receptors on B and T cells activate a similar array of intracellular signaling cascades, including those involving members of the mitogen activated protein (MAP) kinase family, extracellular-signal-related kinase (ERK) and Jun N-terminal kinase (JNK), and nuclear translocation of the transcription factors NF-κB and NF-AT. Each of these pathways is regulated differently and, to some extent, independently. The spectrum of pathways activated by antigen receptors is shifted in one direction during tolerance induction. For example, in anergic B cells which have become tolerant to self antigens, the JNK and NF-κB pathways are not activated in response to B-cell receptor ligation, but the ERK and NF-AT pathways are activated continuously [12] . In anergic T cells, T-cell receptors lose their capacity to activate the JNK, ERK and NF-κB pathways, but they can still stimulate the NF-AT pathway [13] [14] [15] .
CD28 and CD19 appear to augment the same pathways that are diminished in anergic lymphocytes. CD28 stimulation greatly augments activation by the T-cell receptor of JNK and NF-κB, while having no detectable effect on ERK activation [16, 17] . In conjunction with B-cell receptor signaling, CD19 stimulation can lead to activation of both JNK and ERK [18, 19] . The effect of CD19 costimulation on NF-κB is not yet known, although crosslinking CD19 alone can upregulate NF-κB DNA-binding activity in a pre-B-cell line [20] . How CD28 and CD19 augment MAP kinase and NF-κB pathways is unclear; both can activate phosphatidylinositol 3-kinase, but it is still debated whether or not this mediates their costimulatory effects [9, 21, 22] . Other molecules, such as Vav, have been implicated in coreceptor signaling [23] .
Conclusions
The parallels between the CD19 and CD28 pathways, both functional and molecular, begin to reveal the details of how immunity and tolerance responses are balanced. Acquisition of tolerance by anergy weakens antigen receptor signaling pathways, such as those involving JNK and NF-κB, whereas both CD19 and CD28 can enhance antigen-receptor signaling by strengthening these same pathways. Because coreceptor ligands are induced by foreign infections, coreceptors help lymphocytes learn to be tolerant to self and generate immune responses to foreign pathogens. This is reminiscent of neurological learning, where coincident signaling is also required to strengthen synaptic responses. The induction of the form of synaptic plasticity known as long-term potentiation, thought to underlie some forms of learning and memory, requires co-activation of two different subtypes of glutamate receptor [24] . Coincident signaling through more than one receptor is important in many systems; understanding how signals are integrated from different receptors holds the key to a better understanding of cell-fate decisions in the context of adaptive biological processes.
